mild dyspnea. The pregnancy had previously been complicated by diet-controlled gestational diabetes. The patient was healthy otherwise and denied any prior pulmonary problems. She reported an episode of 50-ml bright red hemoptysis accompanied by mild dyspnea on the day of admission. She had no chest pain, and there were no signs or symptoms consistent with a deep venous thrombosis. She also denied any history of hereditary telangiectasia or blood dyscrasia. Physical examination revealed no clubbing or cyanosis, and the lung examination was normal except for occasional crackles over the right lower lobe. There was no evidence of oral or other telangiectasia.
The admission hematocrit was 34.5 percent and the chest roentgenogram was normal. Bronchoscopy revealed an intrapulmonic hemorrhage, but no specific lesion could be seen. A subsequent pulmonary angiogram demonstrated a large arteriovenous malformation (A VM) of the right lower lobe. The patient underwent a coil embolization with good results, and subsequently, a resolution of all symptoms. 
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At 36 weeks of gestation, the patient was readmitted with a second episode of hemoptysis of 50 rnl of bright red blood in a 5-minute period. The patient's hematocrit on the second admission was 41.9 percent. Repeat bronchoscopy verified the persistence of the right lower lobe A VM. Because of continued hemoptysis, the patient was transferred to the intensive care unit and orally intubated. A Fogarty catheter was placed into her right lower lobe bronchus and inflated with 0.75 rnl of nonnal saline to tamponade the AVM. After approximately 6 hours, the balloon was deflated, and the patient immediately produced 10 to 20 rnl of bright red blood. The balloon was re-inflated for an additional 24 hours and then removed without further hemoptysis.
Repeat angiography identified a persistent A VM with recanalization of the previous embolization site. Attempts at embolization were unsuccessful because the previously placed coil precluded vascular access.
Arterial 02 saturation remained above 95 percent. Antepartum fetal heart rate monitoring showed no sign of fetal compromise. Other obstetric parameters were nonnal except for the incidental finding of breech presentation.
Because of the failed re-embolization plus breech presentation, the patient underwent primary low transverse cesarean delivery, resulting in a healthy 3450-gm female infant with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively.
The postoperative course was unremarkable and the patient had no further hemoptysis. She was discharged on postoperative day 4 and continued to do well. She underwent elective segmentectomy with removal of the A VM at 6 months postpartum.
REVIEW OF THE LITERATURE
Pulmonary A VM is a relatively rare condition, but over 200 cases have been described in nonpregnant patients. The etiology of PA VMs may be either congenital or acquired (1) . Approximately half of all PAVMs are associated with the syndrome of hereditary telahgiectasia or Osler-Weber-Rendu disease (2, 3) . Acquired PAVM can result from trauma, schistosomiasis; hepatic cirrhosis, and carcinoma (1).
PAVM DURING PREGNANCY
Nine PA VMs associated with pregnancy have been previously reported (2, (4) (5) (6) and are listed in Table L In many of these cases, PA VM symptoms progressed rapidly during pregnancy, and several had docu- 
ETIOLOGY OF PAVM PROGRESSION
In 1966 Pritchard showed that the average increase in blood volume during a nonnal singleton pregnancy is approximately 1570 rnl, occurring most rapidly during the second trimester (8). Clapp et al. (9) found that by 11 weeks of gestation blood volume has increased by as much as 11 percent. He also noted an increase of 30 to 50 percent in cardiac output in pregnant women. The increase in blood volume and cardiac output results in increased pulmonary blood flow, with preferential flow across the low resistance of the PA VM. The augmentation of flow across the P A VM causes dilatation of the A VM (4, 6) .
Venous distensibility increases by 150 percent during pregnancy with a return to nonnal by 8 to 12 weeks' postpartum (10) . Progesterone causes smooth muscle relaxation and leads to arterial and venous distention, and subsequent decreasing resistance across the A VM, which leads to progression in size and shunt fraction (6, 10, 11) .
The pregnancy-associated increase in steroid hormones results in an increased incidence of A VM rupture. The risk of rupture of splenic artery, renal, and cerebral AVMs are all increased during pregnancy (2) . The data in Table 1 suggest a similar trend with PAVMs during pregnancy.
PRESENTATION
In the nonpregnant patient, usually PA VMs are diagnosed at an average age of 41 years (12) . The reported cases of pregnancy-associated PAVM involve women between the ages of 20 and 37 years old, with the majority of cases presenting in the late second trimester (23-28 weeks' gestation, see Table   1 ).
PA VM, in the asymptomatic, nonpregnant patient, is diagnosed most commonly as an incidental finding on a routine chest x-ray. However, a classic triad of signs and symptoms of P A VM has been reported, which consists of dyspnea, cyanosis, and clubbing (7, 14, 15) . Chronic hypoxia associated with PAVM can result in cyanosis and clubbing. A shunt of at least 20 percent is required to produce hypoxia severe enough to result in these findings (13, 14) .
The most common presenting symptoms associated with PA VM in pregnancy are dyspnea and chest pain. Eight of the nine pregnant women with PA VM episodes of fatigue, dyspnea, heart altae at 50 years old undergoes left lobectomy .
• Parity: term-premature-abortion-living children (as written numerically). t EGA, estimated gestational age when signs and symptoms first occurred. 
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(status postright lobectomy, history of hereditary telangiectasia)
Parity'
presented with a complaint of dyspnea, whereas five reported chest pain, usually pleuritic in nature. These symptoms are very similar to those associated with pulmonary embolus. In two of the cases reported, pulmonary embolus was felt to be the most likely diagnosis before identification of the P A VM. Four of the previously reported P A VMs in pregnancy were noted to have significant clubbing and cyanosis. It should be emphasized that PA VM may initially present in pregnancy with nothing more than the common complaints of fatigue, dyspnea, and musculoskeletal discomfort seen in late pregnancy. Five of the nine previous reports were associated with hemothorax and/or hemoptysis. These symptoms are usually associated with acute rupture of the A VM leading to intrapulmonic and intrapleural hemorrhage. In the nonpregnant popUlation, such complications can be expected in approximately 10 percent of patients (13, 14) . The apparent increased incidence of rupture noted in the pregnant patient is consistent with the tendency noted toward rupture of cerebral, renal, and other A VMs during pregnancy.
Half of the women with reported P A VM during pregnancy also had a history of familial hereditary telangiectasia. This is consistent with the known association of P A VM with hereditary telangiectasia in the general population. Therefore, it is important to inquire about family history and the presence of oral or other telangiectasia in women who present with signs and symptoms consistent with PA VM. These women are more likely to have multiple lesions, symptoms that progress more rapidly, and a higher rate of complications (12) .
An effect of progressive maternal parity on PA VM symptomatology has been proposed (2, 6 (15) reported a case of a woman who had six uncomplicated pregnancies and presented with dyspnea and fatigue during her seventh pregnancy. After this final pregnancy, she suffered from recurrent episodes of dyspnea on exertion, fatigue, and headache and ultimately required a lobectomy.
DIAGNOSIS
P A VM should be considered in all pregnant women who present with acute or chronic pulmonary compromise. Women who present with hemoptysis warrant prompt evaluation including chest roentgenogram, sputum culture, and microscopic analysis, tuberculin skin testing, bronchoscopy, and possibly pulmonary angiography. Bronchoscopy can be used to identify the site of hemorrhage.
The differential diagnosis for hemoptysis during pregnancy is similar to that in the nonpregnant patient. Infection, neoplasm, and vascular disease all must be considered. A complete differential diagnosis for hemoptysis during pregnancy is found in Table 3 .
Physical examination should be used to detect any sign of chronic hypoxia, such as clubbing or cyanosis. Careful pulmonary examination is required to rule out significant hemothorax or effusion. Auscultation of the chest may reveal the presence of a vascular bruit (15, 22) . Any mucocutaneous lesions should also be noted as these would be consistent with the diagnosis of hereditary telangiectasia.
Dines et al. (12) found that in the nonpregnant patient radiographic evidence is present in almost all cases of significant P A VM. Therefore, the chest roentgenogram is a useful diagnostic tool. Two-dimensional echocardiography with the administration of agitated saline has been used by some to screen for vascular malformations (16, 17) . However, pulmonary angiography is necessary for definitive diagnosis (14) . The angiogram will aid in the determination of number, location, and vascular origin of all P A VM present.
MANAGEMENT OF PAVM DURING PREGNANCY
Management of the patient with a PA VM depends on the severity of the individual lesion(s). Initial efforts should be directed to the stabilization of the patient using respiratory support, consisting of supplemental oxygen and bedrest as necessary. Once a source of bleeding has been identified in the patient with hemoptysis, endoscopic placement of a Fogarty catheter can be used to stop ongoing hemorrhage (18) . Patients with severe symptoms or continued bleeding may require more definitive therapy including embolization or surgical removal of the A VM.
Little has been published regarding the appropriate management of P A VM during pregnancy. In the present case, attempts were made to embolize th PA VM. Embolization has become an accepte~ method of treatment for PA VM in the nonpregnant patient (19) (20) (21) (22) . Keller et al. (20) states that emboli_ zation is a safe alternative to surgical treatment whereby a significant amount of normal lung parenchyma is spared (20) . Initial attempts at embolization were successful in our patient, but recanalization and recurrent hemoptysis occurred as the pregnancy progressed. However, in two of the nine case reports patients were treated successfully with coil emboli~ zation without further progression or recanalization of the PAVM (5, 19) .
Lobectomy or segmental resection of the PAVM has also been used as a definitive treatment. One patient with a significant PA VM underwent emergent lobectomy at 29 weeks' gestation with subsequent resolution of all symptoms and eventual cesarean delivery of a healthy male at approximately 37 weeks' gestation (11) .
The optimum method of delivery in the patient with PAVM remains unclear. Vaginal deliveries were accomplished in seven of the cases reported, whereas two required cesarean delivery. One patient with significant hemothorax was treated conservatively with a chest tube and oxygen supplementation and eventually delivered vaginally (16) . Three of the most symptomatic patients (i. e., those that presented with hemothorax or severe hypoxia) were treated with coil embolization or resection while pregnant and eventually delivered vaginally.
Two cases of worsening PAVM eventually required operative abdominal delivery. One patient who presented at 23 weeks of gestation with severe hypoxia required a cesarean delivery at 32 weeks' gestation after progression of her hypoxia (4). A similar case resulted in a cesarean delivery at 32 weeks' gestation (2) .
Vaginal delivery is possible in those cases where no significant symptoms exist or when there is no progression of the disease process. Both of the cases that were delivered abdominally involved women with worsening Pa0 2 or progressive symptoms of rupture, such as hemoptysis or hemothorax. In our case, an abdominal delivery was felt to be most appropriate secondary to the breech presentation of the fetus and to avoid the possibility of continued or . additional rupture of the P A VM. However, a vaginal delivery can be accomplished when no signs or symptoms of progression or significant compromise are present. 
